Condylomata Acuminata
Information
- Disease name
- Condylomata Acuminata
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04537156 | Active, not recruiting | Phase 3 | Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) | September 5, 2020 | December 31, 2027 |
NCT06297187 | Active, not recruiting | Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study | February 23, 2024 | August 2024 | |
NCT02710851 | Active, not recruiting | Phase 2 | Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine | March 24, 2016 | December 30, 2023 |
NCT05056402 | Active, not recruiting | Phase 3 | An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old | September 19, 2021 | December 31, 2025 |
NCT01532102 | Completed | Phase 1/Phase 2 | Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts | February 28, 2012 | May 6, 2013 |
NCT01598779 | Completed | Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population | June 2012 | August 2014 | |
NCT01796821 | Completed | Phase 2 | Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs) | August 2014 | October 2018 |
NCT02015260 | Completed | Phase 2 | A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts | September 2001 | May 2003 |
NCT02405520 | Completed | Phase 1 | Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine | March 26, 2015 | May 20, 2022 |
NCT02535104 | Completed | Phase 1/Phase 2 | Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV) | February 2016 | September 2016 |
NCT04782895 | Completed | Phase 3 | Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age | March 14, 2021 | July 25, 2022 |
NCT03546842 | Completed | Phase 3 | Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017) | June 29, 2018 | January 29, 2019 |
NCT03813940 | Completed | Phase 1 | Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) | January 3, 2019 | April 1, 2021 |
NCT03935204 | Completed | Phase 2 | Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) | May 13, 2019 | April 1, 2021 |
NCT03981822 | Completed | Phase 2 | A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | June 25, 2019 | July 8, 2020 |
NCT00090285 | Completed | Phase 3 | An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020) | September 3, 2004 | April 3, 2017 |
NCT00449982 | Completed | Phase 3 | Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts | July 2003 | August 2004 |
NCT00973856 | Completed | N/A | Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands | September 2009 | January 2012 |
NCT06430190 | Not yet recruiting | N/A | Peginterferon α-2b Combined CO2 Laser in Condylomata Acuminata | May 2024 | December 2025 |
NCT06197802 | Not yet recruiting | Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women | January 10, 2024 | December 1, 2024 | |
NCT05087849 | Recruiting | Phase 1/Phase 2 | Intralesional HPV Vaccine for Condylomata | April 15, 2022 | July 1, 2024 |
NCT02520986 | Recruiting | N/A | Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma | December 2016 | December 2024 |
NCT03158974 | Terminated | Phase 2 | A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of External Genital Warts | August 1, 2017 | June 17, 2018 |
NCT03853785 | Unknown status | Phase 3 | Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts | February 2020 | December 2021 |
NCT01483794 | Unknown status | Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, Chile | November 2011 | April 2012 | |
NCT03158480 | Unknown status | N/A | Safety and Efficacy of Immune Therapy for Condyloma | June 25, 2017 | June 30, 2019 |
NCT00365443 | Withdrawn | Phase 2 | Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003) | October 2006 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D003218